TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/25 18:49 | 1/27/25 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 4 | 5 | S.d | -61 | 3.83 | 0 | -16 | 377 | D | |||||||||||||||
3/18/25 16:01 | 3/14/25 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 4 | S.d | -3,323 | 70.95 | 0 | -47 | 126 | D | |||||||||||||||
3/11/25 16:15 | 3/7/25 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | 1 | 1 | S | -103 | 53.00 | 0 | -2 | 9 | D | |||||||||||||||
2/26/25 16:18 | 2/24/25 | MEDP | Medpace Holdings, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S.d | -1,383 | 345.59 | 0 | -4 | 26 | D | |||||||||||||||
2/21/25 16:36 | 2/20/25 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S | -715 | 162.50 | 0 | -4 | 20 | D | ||||||||||||||||
2/20/25 16:34 | 2/18/25 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | 5 | 8 | S.m | -436 | 3.94 | 0 | -111 | 2,014 | D | |||||||||||||||
2/19/25 20:51 | 2/19/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 6 | S.dm | -475 | 3.42 | 0 | -139 | 4,349 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |